If you develop signs of hypoglycemia after using Ozempic (such as headache, drowsiness, or hunger), talk with your doctor
Treat hypoglycaemia with 1520 g of fast-acting carbohydrate (such as glucose tablets or fruit juice) and recheck glucose after 15 minutes
It works upstream in the hormone cascade, offering a physiologic and highly controlled way to enhance hormone levels

The convenient format supports consistency and ease of daily use.* Metabolic & Wellness Support: GLP-1/GIP therapy may help support healthy glucose metabolism, insulin response, and overall metabolic efficiency when paired with healthy lifestyle habits.* Improved Confidence & Lifestyle Support: As patients progress toward their goals, many experience improvements in mobility, energy, confidence, and overall quality of life, supporting a healthier and more active lifestyle.* Encourages Healthier Eating Habits: By supporting appetite regulation and satiety, GLP-1/GIP therapy helps patients make healthier nutritional decisions and maintain improved portion control.* Supports Daily Energy & Motivation: Improved metabolic function and wellness support may contribute to increased daily energy, physical activity, and motivation to maintain healthier routines.* Provides a Comfortable Alternative to Injections: Sublingual oral drops remove the stress and inconvenience associated with needles, making treatment more approachable for many patients.* Pairs Well with Lifestyle Improvements: GLP-1/GIP therapy is most effective when combined with proper hydration, balanced nutrition, movement, and consistent wellness habits.* A Modern Approach to Wellness: GLP-1/GIP therapies represent one of the most advanced and clinically studied approaches to metabolic wellness and weight management available today.* Potential Side Effects: Some patients may experience mild gastrointestinal symptoms such as nausea, bloating, constipation, diarrhea, or stomach discomfort during the early stages of therapy

It cant be used with other semaglutide-containing products (such as Ozempic, Rybelsus) or other GLP-1 receptor agonist medicines
Data from the SURMOUNT-1 trial showed increases of around 2-3 beats per minute compared to placebo after 72 weeks